欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/1480/001
药品名称Piperacillin/Tazobactam Viatris 2 g/0.25 g
活性成分
    • Piperacillin 2.0 g
    • Tazobactam 0.25 g
剂型Powder for solution for infusion
上市许可持有人Viatris Ltd Damastown Industrial Park Mulhuddart Dublin 15 Dublin Ireland
参考成员国 - 产品名称Netherlands (NL)
Piperacilline/Tazobactam Viatris 2 g/250 mg, poeder voor oplossing voor infusie.
互认成员国 - 产品名称
    • Belgium (BE)
      Piperacilline-Tazobactam Viatris 2 g-250 mg
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Portugal (PT)
    • Greece (GR)
    • Cyprus (CY)
    • Slovenia (SI)
    • Malta (MT)
许可日期2009/07/21
最近更新日期2025/01/14
药物ATC编码
    • J01CR05 piperacillin and beta-lactamase inhibitor
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase